[Anti-tumour necrosis factor treatment in HIV-positive patients with psoriatic arthritis].
Cobo Ibáñez
Tatiana
T
Zamora
Francisco
F
Herranz
Pedro
P
Steiner
Martina
M
D000328:Adult; D015535:Arthritis, Psoriatic / Q000188:drug therapy* / Q000209:etiology*; D000068800:Etanercept; D006679:HIV Seropositivity / Q000150:complications*; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D008297:Male; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept